Position in RPRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$18,912,298
+$12,016,131 QoQ
Shares Held
337,298
+134.6% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#110
of 644 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CAPTRUST FINANCIAL ADVISORS holds $167,363,866 across 124 Biotechnology names. RPRX ranks #2 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
36,464 | $22,736,762 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
337,298 | $18,912,298 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
35,471 | $17,619,509 | |
| 4 | EXEL |
Exelixis, Inc.
|
303,042 | $16,488,515 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
34,607 | $10,938,926 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
125,946 | $9,857,793 | |
| 7 | CELC |
Celcuity Inc.
|
71,445 | $7,474,575 | |
| 8 | INCY |
Incyte Corp
|
50,301 | $5,702,121 |
All Filings in RPRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,912,298 | 337,298 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,896,167 | 143,760 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $538,796 | 13,944 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $416,833 | 11,815 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $454,446 | 12,613 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $376,268 | 12,087 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $378,287 | 14,829 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $829,689 | 29,328 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $815,465 | 30,924 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $1,016,149 | 33,459 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,096,858 | 39,048 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,544,808 | 56,920 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,895,582 | 61,665 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $2,220,853 | 61,639 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,594,013 | 65,638 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,577,707 | 64,154 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $12,107 | 288 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $10,090 | 259 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $5,857 | 147 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,480 | 207 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $286 | 7 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||